누릭스 테라퓨틱스 (NRIX)

05:20 AM

How institutional ownership impacts Nurix Therapeutics Inc. stock2025 Momentum Check & Safe Capital Preservation Plans - newser.com

05:20 AM

04:45 AM

Full technical analysis of Nurix Therapeutics Inc. stockJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com

04:45 AM

04:18 AM

How moving averages guide Nurix Therapeutics Inc. tradingMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com

04:18 AM

01:49 AM

Will Nurix Therapeutics Inc. stock go up soonPortfolio Value Summary & Consistent Profit Trading Strategies - newser.com

01:49 AM

01:47 AM

Nurix Therapeutics CFO van Houte sells $40k in shares By Investing.com - Investing.com UK

01:47 AM

01:34 AM

Will Nurix Therapeutics Inc. stock deliver consistent dividendsQuarterly Trade Review & Risk Controlled Daily Plans - newser.com

01:34 AM

01:05 AM

Can Nurix Therapeutics Inc. recover in the next quarter2025 Technical Overview & Weekly High Return Forecasts - newser.com

01:05 AM

Oct 30, 2025

Nurix Therapeutics CLO ring sells shares for $46,631 By Investing.com - Investing.com Canada

Oct 30, 2025

Oct 30, 2025

Nurix therapeutics CSO Hansen sells $52k in shares By Investing.com - Investing.com Philippines

Oct 30, 2025

Oct 30, 2025

Nurix Therapeutics CFO van Houte sells $40k in shares - Investing.com

Oct 30, 2025

Oct 30, 2025

Nurix therapeutics CSO Hansen sells $52k in shares - Investing.com

Oct 30, 2025

Oct 30, 2025

Nurix Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Oct 30, 2025

Oct 30, 2025

Nurix Therapeutics (Nasdaq: NRIX) to join Stifel Nov 13 and Jefferies Nov 19 webcasts - Stock Titan

Oct 30, 2025

Oct 30, 2025

Is Nurix Therapeutics Inc. building a consolidation baseInflation Watch & High Return Trade Guides - newser.com

Oct 30, 2025

Oct 29, 2025

HC Wainwright Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $28.00 - MarketBeat

Oct 29, 2025

Oct 29, 2025

Visual trend scoring systems applied to Nurix Therapeutics Inc.July 2025 Retail & Technical Confirmation Trade Alerts - newser.com

Oct 29, 2025

Oct 29, 2025

AlphaQuest LLC Boosts Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat

Oct 29, 2025

Oct 29, 2025

Nurix Therapeutics Inc. stock daily chart insightsJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com

Oct 29, 2025

Oct 29, 2025

What technical charts say about Nurix Therapeutics Inc. stockTrade Risk Report & Low Risk High Reward Ideas - newser.com

Oct 29, 2025

Oct 28, 2025

Nurix Therapeutics (NASDAQ:NRIX) Trading 7.7% HigherHere's Why - MarketBeat

Oct 28, 2025

Oct 28, 2025

HC Wainwright & Co. Maintains Nurix Therapeutics (NRIX) Buy Recommendation - Nasdaq

Oct 28, 2025

Oct 28, 2025

Nurix stock price target lowered to $28 at H.C. Wainwright on trial updates - Investing.com UK

Oct 28, 2025

Oct 28, 2025

Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) 34% Price Boost Is Out Of Tune With Revenues - 富途牛牛

Oct 28, 2025

Oct 28, 2025

Will Nurix Therapeutics Inc. bounce back from current supportWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com

Oct 28, 2025

Oct 28, 2025

Applying chart zones and confluence areas to Nurix Therapeutics Inc.Weekly Trade Report & Long-Term Growth Stock Strategies - newser.com

Oct 28, 2025

Oct 27, 2025

Nurix Therapeutics closes $250 million stock offering By Investing.com - Investing.com Philippines

Oct 27, 2025

Oct 27, 2025

Why Nurix Therapeutics Inc. stock is seen as undervaluedQuarterly Trade Review & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - TipRanks

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics’ NX-5948 Study: A Potential Game-Changer in Drug Delivery - TipRanks

Oct 27, 2025

Oct 27, 2025

Fenwick Represents Nurix Therapeutics in its $250M Registered Common Stock Offering - fenwick.com

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics closes $250 million stock offering - Investing.com

Oct 27, 2025

Oct 27, 2025

Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock - Investing News Network

Oct 27, 2025

Oct 27, 2025

Nurix (NASDAQ: NRIX) closes 24.5M-share offering at $10.21 for CLL, autoimmune - Stock Titan

Oct 27, 2025

Oct 27, 2025

Leerink Partnrs Has Bullish Outlook for NRIX FY2025 Earnings - MarketBeat

Oct 27, 2025

Oct 27, 2025

Can Nurix Therapeutics Inc. stock hit record highs againJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com

Oct 27, 2025